Dr Melanie Goward on life sciences in Wales
Dr Melanie Goward, Senior Investment Executive of Finance Wales
considers what makes Wales such a hot-bed of opportunity for
high-quality life sciences companies.
Whether its medical devices, diagnostics, pharmaceuticals or
healthcare technology, life sciences investments are a significant
and growing part of Finance Wales’ portfolio.
In total they now account for over 60% of the value of our early
stage technology investments.
Supporting the sector
As well as the backing of a strong investor like Finance Wales,
there’s also a great deal on offer for life science companies
establishing in Wales:
- World-class academic work
- Facilitated access to the NHS
- High-quality facilities
- Range of expertise and people skills
- Government financial support
The life sciences sector is highly regulated and gaining
regulatory approval can be a timely and uncertain process.
Our investments match typical sector funding cycles and we can
invest at early proof-of-concept and pre-revenue stages through to
development and product launch.
We can invest up to £1 million initially and then
potentially follow its investments with more significant sums.
Additional fire-power comes from our ability to co-invest with
private and institutional investors and as well as tie-up
Fusion IP which has successfully invested £4.2 million in seven
An extensive network also offers benefits ranging from
sign-posting the right regulatory advice to strengthening
As a supportive long-term investor our goal is to ensure we do
our utmost to help the companies we invest in.
New Welsh Life Science Investment Fund
With the recent announcement of a £100 million Welsh Science
Investment Fund there's a lot going on in Wales to cement the
future of its life sciences sector.